Tesamorelin Peptide: Premium GHRH Analogue for Laboratory Research

Advance your cellular and metabolic testing pipelines with our premium tesamorelin peptide formulation. Tesamorelin is a synthetic peptide analogue consisting of all 44 amino acids of human growth hormone-releasing hormone (GHRH), modified with a trans-3-hexenoic acid group at its N-terminal position. This specific biochemical structure significantly enhances its enzymatic stability against dipeptidyl peptidase-4 (DPP-4) degradation, resulting in a prolonged half-life and extended interaction capabilities in experimental settings compared to endogenous GHRH.

In vitro studies and laboratory research models demonstrate that this compound interacts directly with specific GHRH receptors on pituitary somatotrophs, stimulating the synthesis and pulsatile secretion of growth hormone (GH). This mechanism triggers an upstream cascade that elevates insulin-like growth factor 1 (IGF-1) levels. Furthermore, molecular pathway analysis indicates that this interaction downregulates adipose-related signaling mechanisms, making it a critical asset for investigating lipolysis (breaking down fat) and lipid metabolism dynamics within specialized cell cultures.

Analytical and Laboratory Specifications

• Enhanced Stability Profile: Modified N-terminus design engineered to resist rapid enzymatic cleavage and preserve structural integrity during assay preparation.

• Strict Purity Verification: High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) verified to ensure uncompromised purity for chemical analysis.

• OptimumGenix Quality Standards: Lyophilized under sterile laboratory environments and shipped via secure distribution pipelines to prevent premature thermal degradation.